EP3122742
Kvínoxalín-afleiður gagnlegar sem FGFR-kínasa-mótarar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.3.2015EP published:
19.9.2018EP application number:
15720269.8
EP translation filed:
18.12.2018Grant published:
15.1.2019EPO information:
European Patent Register
Max expiry date:
25.3.2035Expiry date:
25.3.2027Next due date:
31.3.2027
Title:
QUINOXALINE DERIVATIVES USEFUL AS FGFR KINASE MODULATORS
Timeline
Today
26.3.2015EP application
19.9.2018EP Publication
18.12.2018Translation submitted
15.1.2019Registration published
25.3.2027Expires
Owner
Name:
Astex Therapeutics LtdAddress:
436 Cambridge Science Park, Milton Road,, CambridgeCambridgeshire CB4 0QA, GB
Inventor
Name:
VERMEULEN, WimAddress:
Beerse, BE
Name:
HOSTYN, Steven AnnaAddress:
Beerse, BE
Name:
CUYCKENS, Filip Albert CelineAddress:
Beerse, BE
Name:
JONES, Russell MarkAddress:
Binningen, CH
Name:
BROGGINI, Diego Fernando DomenicoAddress:
Schaffhausen, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
14161820Date:
26.3.2014Country:
EP
Classification
Categories:
C07D 403/14, A61K 31/4985, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 29.3.2019
Expires: 25.3.2020
Payer: Tego ehf.
Number: 6
Paid: 24.3.2020
Expires: 25.3.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 22.3.2021
Expires: 25.3.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 21.3.2022
Expires: 25.3.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 27.2.2023
Expires: 25.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.2.2024
Expires: 25.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.2.2025
Expires: 25.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 28.3.2026
Expires: 25.3.2027
Payer: Árnason Faktor ehf.